Press "Enter" to skip to content

New patent expiration for Almirall drug ALTABAX

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Almirall drug ALTABAX

Annual Drug Patent Expirations for ALTABAX
Annual Drug Patent Expirations for ALTABAX

Altabax is a drug marketed by Almirall and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has sixty-three patent family members in thirty-five countries.

The generic ingredient in ALTABAX is retapamulin. One supplier is listed for this compound. Additional details are available on the retapamulin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Almirall drug ALTABAX
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions